Friday, October 30, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 23, 2026

Adeia Announces Record Fourth Quarter and Full Year 2025 Financial Results

View original at finance.yahoo.com
Adeia Announces Record Fourth Quarter and Full Year 2025 Financial Results Adeia Inc…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The past year was exceptional, both financially and operationally, with record annual revenue and excellent operating income and adjusted EBITDA all exceeding high end of guidance range

    80% confidence
  • Signed nine deals during Q4, including four with new customers, notably entering significant long-term license agreement with Disney

    80% confidence
  • Expanded IP portfolios by 13% through combination of internal R&D and strategic tuck-in acquisitions

    80% confidence
  • RapidCool thermal solution is now being evaluated by multiple technology leaders involved in the AI semiconductor supply chain

    80% confidence
  • With recent realignment of senior leadership team, better positioned for long-term scale and growth

    80% confidence
  • Non-Pay-TV recurring revenue grew 22% in 2025, validating strategy to diversify revenue streams

    80% confidence
  • Signed 26 agreements in 2025 across diverse customer base, with record 12 of 26 deals with new customers

    80% confidence
  • Full year 2026 revenue guidance of $395-435 million with adjusted EBITDA of $213.4-245.4 million

    80% confidence
  • Finished the year with strong momentum, delivering record fourth-quarter revenue of $182.6 million, along with quarterly records in operating income and adjusted EBITDA

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com